Form 4: TELA Bio, Inc. Executive Megan Smeykal Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Chief Accounting Officer Megan Smeykal reports acquisition and disposal of TELA Bio, Inc. common stock and restricted stock units.
Summary
- On February 19, 2025, Megan Smeykal, Chief Accounting Officer and Controller of TELA Bio, Inc., reported changes in her beneficial ownership of the company's securities.
- Smeykal acquired 9,400 shares of common stock at $0.
- She now beneficially owns 39,479 shares.
- These restricted stock units will vest in four equal annual installments beginning on February 19, 2026, subject to continuous service.
Sentiment
Score: 5
Explanation: This is a routine filing related to changes in beneficial ownership, with no clear positive or negative implications.
Future Outlook
The restricted stock units will vest in four equal annual installments beginning on February 19, 2026, subject to the Reporting Person's continuous service through the applicable vesting dates.
Key Dates
| Date | Description |
|---|---|
| July 31, 2024 | 1,079 shares acquired under the Issuer's employee stock purchase plan |
| February 19, 2025 | Date of transaction: acquisition of 9,400 shares of common stock |
| February 19, 2026 | Vesting start date for restricted stock units in four equal annual installments |
| February 21, 2025 | Date of signature |
Keywords
beneficial ownership, Form 4, TELA Bio, stock, securities, Smeykal, restricted stock units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.